NANO Nuclear Continues to Attract Top Tier talent to Propel the Development of its Innovative Microreactor Technologies New ...
Alvotech acquires Xbrane’s R&D operations and the biosimilar candidate XB003. Xbrane retains some pre-clinical development programs, that it intends to commercialize, and will continue operating as a ...